The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer.

Bird joins BioPorto from his role at Roche Diagnostics as Head of Medical and Scientific Affairs in North America. After over 10 years with this medical and scientific affairs organisation, Christopher will now be responsible for leading the development of diagnostic products at BioPorto.

Image Credit: Proactive Investors

«« Creative Solutions for Staff Retention


The 2019 EHMA Annual Conference »»



Latest Articles

BioPorto, Roche, Chief Medical Officer, Christopher Bird, Roche Diagnostics, Medical and Scientific Affairs, Head of Medical and Scientific Affairs, Bird, Christopher, medical diagnostic The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer.